Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Subtenon Autologous Platelet-Rich Plasma in Inherited and Degenerative Retinal Diseases
NCT07341919Phase 2Active, not recruiting
- Sponsor
- Rubens Camargo Siqueira
- Start
- Jan 2025
- Primary completion
- Mar 2026
- Modality
- Adoptive Cell Transfer
- Countries
- 1
01
Overview
A Phase 2 trial of autologous platelet-rich plasma eye drops in retinitis pigmentosa (RP), geographic atrophy (GA), sponsored by Rubens Camargo Siqueira. Started Jan 2025; status: active, not recruiting.
02
Drugs
autologous platelet-rich plasma eye drops
03
Conditions
retinitis pigmentosa (RP)geographic atrophy (GA)
Beyond the preview
Go deeper on NCT07341919.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT07341919.